Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 55% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 13.7% — below-average profitability
CORE LABORATORIES INC. (CLB) is a Basic Materials company operating in Oil & Gas Field Services, NEC, listed on the NYSE , with a market capitalisation of $726 million . Key value metrics: P/E ratio 19.9, P/B ratio 2.73, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 4 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
CORE LABORATORIES INC. — Fundamental Analysis Summary
CORE LABORATORIES INC. (CLB) is currently trading 55% above its Graham Number of $10.14, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 19.9x.
On financial health, CLB shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 13.7% (sector average: -1.2%), and manageable leverage with a debt-to-equity ratio of 0.42.
StockPik's composite Value Score for CLB is 84/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CLB reports a moderate gross margin of 20.6% (sector average: 12.8%) and a solid operating margin of 11.6%.
CLB shows revenue growing at 1% year-over-year, with earnings declining at 6%.
CLB pays a modest dividend yield of 0.3%.